Malignant Degeneration of a Mature Ovarian Teratoma.


Journal

Case reports in obstetrics and gynecology
ISSN: 2090-6684
Titre abrégé: Case Rep Obstet Gynecol
Pays: United States
ID NLM: 101576454

Informations de publication

Date de publication:
2021
Historique:
received: 14 03 2021
accepted: 09 07 2021
entrez: 2 8 2021
pubmed: 3 8 2021
medline: 3 8 2021
Statut: epublish

Résumé

Mature cystic teratoma is the most common type of ovarian germ cell neoplasm, but occasionally, it can undergo malignant transformations, especially in postmenopausal women. These secondary malignant neoplasms are most commonly squamous cell carcinomas. The absence of clinical and radiological specificity of this transformation means that the diagnosis remains purely histological. Data is insufficient regarding the appropriate management given their rarity. However, the treatment is multidisciplinary and is based on surgery and a platinum-based chemotherapy regimen. We report the case of a 53-year-old postmenopausal female patient with malignant transformation of the ovarian teratoma who was treated surgically and whose outcome was favorable. The diagnosis of the teratoma was evoked on imaging, while the diagnosis of squamous cell carcinoma was revealed on histology. Malignant transformation is an uncommon complication of mature ovarian teratomas. No clinical, radiological, or biological sign is specific; therefore, resection of any ovarian mass, even asymptomatic, is required.

Identifiants

pubmed: 34336320
doi: 10.1155/2021/5527467
pmc: PMC8324364
doi:

Types de publication

Case Reports

Langues

eng

Pagination

5527467

Informations de copyright

Copyright © 2021 Mariam Mahtate et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Ann Diagn Pathol. 2015 Jun;19(3):103-6
pubmed: 25773307
Fertil Steril. 1997 Sep;68(3):501-5
pubmed: 9314922
Gynecol Obstet Fertil. 2007 Oct;35(10):1005-8
pubmed: 17916437
Int J Gynecol Cancer. 2003 Jul-Aug;13(4):558-63
pubmed: 12911740
Lancet Oncol. 2008 Dec;9(12):1173-80
pubmed: 19038764
Arch Gynecol Obstet. 2005 Apr;271(4):355-7
pubmed: 15551144
Gynecol Oncol. 1988 Feb;29(2):222-30
pubmed: 3276581
Int J Gynecol Cancer. 2006 Jan-Feb;16(1):140-4
pubmed: 16445624
Obstet Gynecol. 1997 Jun;89(6):1017-22
pubmed: 9170484
Eur J Gynaecol Oncol. 2005;26(4):391-2
pubmed: 16122185

Auteurs

Mariam Mahtate (M)

Gynecology-Obstetrics and Endoscopy Department, Maternity Souissi, University Hospital Center IBN SINA, University Mohammed V, Rabat, Morocco.

Sarah Talib (S)

Gynecology-Obstetrics and Endocrinology Department, Maternity Souissi, University Hospital Center IBN SINA, University Mohammed V, Rabat, Morocco.

Aziz Slaoui (A)

Gynecology-Obstetrics and Endocrinology Department, Maternity Souissi, University Hospital Center IBN SINA, University Mohammed V, Rabat, Morocco.

Najia Zeraidi (N)

Gynecology-Obstetrics and Endoscopy Department, Maternity Souissi, University Hospital Center IBN SINA, University Mohammed V, Rabat, Morocco.

Amina Lakhdar (A)

Gynecology-Obstetrics and Endoscopy Department, Maternity Souissi, University Hospital Center IBN SINA, University Mohammed V, Rabat, Morocco.

Brahim Rhrab (B)

Gynecology-Obstetrics and Endoscopy Department, Maternity Souissi, University Hospital Center IBN SINA, University Mohammed V, Rabat, Morocco.

Aziz Baydada (A)

Gynecology-Obstetrics and Endoscopy Department, Maternity Souissi, University Hospital Center IBN SINA, University Mohammed V, Rabat, Morocco.

Classifications MeSH